These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21224307)

  • 1. Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.
    Yoshimura R; Shibuya H; Hayashi K; Toda K; Watanabe H; Miura M
    Br J Radiol; 2011 Oct; 84(1006):930-8. PubMed ID: 21224307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
    Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
    Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
    Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
    Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation doses of medical radiation workers performing low-dose-rate brachytherapy with
    Konishi M; Shimabukuro K; Hirokawa J; Sadatoki T; Katsuta T; Imano N; Nishibuchi I; Murakami Y; Kakimoto N
    Oral Radiol; 2024 Apr; 40(2):234-241. PubMed ID: 38108954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
    Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions.
    Fellin G; Mirri MA; Santoro L; Jereczek-Fossa BA; Divan C; Mussari S; Ziglio F; La Face B; Barbera F; Buglione M; Bandera L; Ghedi B; Di Muzio NG; Losa A; Mangili P; Nava L; Chiarlone R; Ciscognetti N; Gastaldi E; Cattani F; Spoto R; Vavassori A; Giglioli FR; Guarneri A; Cerboneschi V; Mignogna M; Paoluzzi M; Ravaglia V; Chiumento C; Clemente S; Fusco V; Santini R; Stefanacci M; Mangiacotti FP; Martini M; Palloni T; Schinaia G; Lazzari G; Silvano G; Magrini S; Ricardi U; Santoni R; Orecchia R
    Br J Radiol; 2016 Sep; 89(1065):20150981. PubMed ID: 27384381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: a comparison of outcomes.
    Pohar S; Haq R; Liu L; Koniarczyk M; Hahn S; Damron T; Aronowitz JN
    Brachytherapy; 2007; 6(1):53-7. PubMed ID: 17284387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer.
    Agarwal M; Chhabra AM; Amin N; Braccioforte MH; Molitoris JK; Moran BJ
    Brachytherapy; 2018; 17(6):882-887. PubMed ID: 30143400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant brachytherapy for oral squamous cell carcinomas: a single-center experience comparing low-dose and pulsed-dose-rate techniques.
    Mattei P; Chabrillac E; Cabarrou B; Dupret-Bories A; Vergez S; Sarini J; Lopez R; Piram L; Brun T; Modesto A
    Strahlenther Onkol; 2022 Feb; 198(2):150-158. PubMed ID: 34786604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
    Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
    Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.
    Vuolukka K; Auvinen P; Palmgren JE; Voutilainen T; Aaltomaa S; Kataja V
    Brachytherapy; 2019; 18(5):583-588. PubMed ID: 31227400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.
    Inoue T; Inoue T; Yamazaki H; Koizumi M; Kagawa K; Yoshida K; Shiomi H; Imai A; Shimizutani K; Tanaka E; Nose T; Teshima T; Furukawa S; Fuchihata H
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):53-8. PubMed ID: 9588917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat brachytherapy for patients with residual or recurrent tumors of oral cavity.
    Yoshimura R; Shibuya H; Hayashi K; Nakagawa K; Toda K; Watanabe H; Kaida A; Miura M
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1198-204. PubMed ID: 22099049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx.
    Stannard C; Maree G; Tovey S; Hunter A; Wetter J
    Brachytherapy; 2014; 13(4):405-12. PubMed ID: 24818781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.